BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35469568)

  • 1. Amalgamation of Nanotechnology for Delivery of Bioactive Constituents in Solid Tumors.
    Parveen R; Mohapatra S; Ahmad S; Husain SA
    Curr Drug Deliv; 2023; 20(5):457-482. PubMed ID: 35469568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review.
    Gorain B; Karmakar V; Sarkar B; Dwivedi M; Leong JTL; Toh JH; Seah E; Ling KY; Chen KY; Choudhury H; Pandey M
    Int J Biol Macromol; 2023 Dec; 253(Pt 1):126623. PubMed ID: 37657573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based drug delivery systems and herbal medicines: a review.
    Bonifácio BV; Silva PB; Ramos MA; Negri KM; Bauab TM; Chorilli M
    Int J Nanomedicine; 2014; 9():1-15. PubMed ID: 24363556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment.
    Hu Y; Song J; Feng A; Li J; Li M; Shi Y; Sun W; Li L
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
    Qiu C; Zhang JZ; Wu B; Xu CC; Pang HH; Tu QC; Lu YQ; Guo QY; Xia F; Wang JG
    J Nanobiotechnology; 2023 Nov; 21(1):456. PubMed ID: 38017573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
    Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N
    J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic nanosystems for oncology nanomedicine.
    Gonçalves AS; Macedo AS; Souto EB
    Clin Transl Oncol; 2012 Dec; 14(12):883-90. PubMed ID: 22855194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
    Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
    Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology for the delivery of phytochemicals in cancer therapy.
    Xie J; Yang Z; Zhou C; Zhu J; Lee RJ; Teng L
    Biotechnol Adv; 2016; 34(4):343-353. PubMed ID: 27071534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal and vesicular delivery system for herbal bioactive constituents.
    Pandey R; Bhairam M; Shukla SS; Gidwani B
    Daru; 2021 Dec; 29(2):415-438. PubMed ID: 34327650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment.
    Li Q; Xiong Y; Ji C; Yan Z
    Biomed Res Int; 2019; 2019():9083068. PubMed ID: 31915707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.
    Li C; Zhang J; Zu YJ; Nie SF; Cao J; Wang Q; Nie SP; Deng ZY; Xie MY; Wang S
    Chin J Nat Med; 2015 Sep; 13(9):641-52. PubMed ID: 26412423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
    Salman Ul Islam ; Ahmed MB; Mazhar Ul-Islam ; Shehzad A; Lee YS
    Curr Pharm Des; 2019; 25(34):3620-3632. PubMed ID: 31605574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.